Pricing Log in Create free account
Saturday 17 October 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.

72.54 0.02 +0.03%
Market cap
$11.4B
P/E
62.0×
Fwd P/E
37.6×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bio-Techne Corp (TECH) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Bio-Techne Corp (TECH) trades at a EV/FCF of 42.8×. Over the past ten years it has ranged from 17.2× (January 2016) to 79.1× (February 2021); the current reading is higher than 44% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2026 41.7× 28.77%
FY2025 32.4× (33.41%)
FY2024 48.6× (19.14%)
FY2023 60.1× 23.85%
FY2022 48.5× (14.92%)
FY2021 57.0× (13.98%)
FY2020 66.3× 25.58%
FY2019 52.8× 38.08%
FY2018 38.2× 7.50%
FY2017 35.6× 8.01%

Quarterly newest first

Period EV/FCF Change
Jun 2026 41.7× 37.44%
Mar 2026 30.3× (27.03%)
Dec 2025 41.5× 5.58%
Sep 2025 39.3× 21.61%
42 more quarters

Against its own ten years

Low 17.2× High 79.1×
Ten-year median 45.2×
Current reading's percentile 39

EV/FCF against peers

Company EV/FCF
MDGL Madrigal Pharmaceuticals, Inc. compare −60.3×
IBRX ImmunityBio, Inc. compare −36.6×
BBIO BridgeBio Pharma, Inc. compare −32.0×
SMMT Summit Therapeutics PLC compare −23.5×
PCVX Vaxcyte, Inc. compare −8.6×
BMRN BioMarin Pharmaceutical Inc. compare 19.2×
KRYS Krystal Biotech, Inc. compare 33.0×
TECH Bio-Techne Corp 42.8×
CORT Corcept Therapeutics Incorporated compare 106×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on TECH